Obstructive Sleep Apnea (OSA) is a common sleep-related breathing disorder characterized by repetitive episodes of interrupted breathing due to obstructed upper airways, usually resulting from a complex multifactorial interaction between anatomical and non-anatomical phenotypes. The disorder is associated with major comorbidities including an increased risk of hypertension, cardiovascular disorders, and metabolic conditions. In addition, OSA has also been associated with mental health issues. Despite the current efforts and the release of new interfaces and machines, positive airway pressure treatment still has suboptimal adherence and tolerance levels, highlighting the need for new treatment options. In recent years, various innovative approaches such as neuromodulation, breathing assistance implantation, nerve stimulation, and myofunctional therapy have emerged. However, there is still much to understand regarding the safety, efficacy, and patient acceptance of these new therapies. Furthermore, given the increasing knowledge of the pathophysiological mechanisms leading to OSA, further innovation in treatment strategies is needed.
This Research Topic aims to address innovative OSA treatments to facilitate and promote discussion around this important topic while disseminating knowledge to advance our understanding of this complex multifactorial disorder.
Keywords:
Sleep Apnea, Sleep and Breathing
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
Obstructive Sleep Apnea (OSA) is a common sleep-related breathing disorder characterized by repetitive episodes of interrupted breathing due to obstructed upper airways, usually resulting from a complex multifactorial interaction between anatomical and non-anatomical phenotypes. The disorder is associated with major comorbidities including an increased risk of hypertension, cardiovascular disorders, and metabolic conditions. In addition, OSA has also been associated with mental health issues. Despite the current efforts and the release of new interfaces and machines, positive airway pressure treatment still has suboptimal adherence and tolerance levels, highlighting the need for new treatment options. In recent years, various innovative approaches such as neuromodulation, breathing assistance implantation, nerve stimulation, and myofunctional therapy have emerged. However, there is still much to understand regarding the safety, efficacy, and patient acceptance of these new therapies. Furthermore, given the increasing knowledge of the pathophysiological mechanisms leading to OSA, further innovation in treatment strategies is needed.
This Research Topic aims to address innovative OSA treatments to facilitate and promote discussion around this important topic while disseminating knowledge to advance our understanding of this complex multifactorial disorder.
Keywords:
Sleep Apnea, Sleep and Breathing
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.